Exact Mass: 372.2485

Exact Mass Matches: 372.2485

Found 79 metabolites which its exact mass value is equals to given mass value 372.2485, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

8,8a-Deoxyoleandolide

(3R,4S,5R,6S,7S,9R,11R,12S,13R,14R)-4,6,12-trihydroxy-3,5,7,9,11,13,14-heptamethyl-oxacyclotetradecane-2,10-dione

C20H36O6 (372.2512)


8,8a-Deoxyoleandolide is a naturally occurring sesquiterpene lactone, which is a type of organic compound derived from the metabolism of plants. It is characterized by the absence of an oxygen atom at the 8 and 8a positions in its molecular structure, which differentiates it from the related compound oleandolide. Sesquiterpene lactones are known for their biological activities, such as cytotoxic, anti-inflammatory, and antimicrobial properties. 8,8a-Deoxyoleandolide may be found in various plant species and could be of interest for pharmaceutical research due to its potential therapeutic effects. The compound's structure typically includes a lactone ring fused with a sesquiterpene framework, and it may exhibit various substituents depending on its source and the specific plant it is derived from. 13-Deethyl-6,12-dideoxy-13-methylerythronolide A. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=53428-54-9 (retrieved 2024-07-15) (CAS RN: 53428-54-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Gentian Violet

4-{bis[4-(dimethylamino)phenyl]methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium

C25H30N3+ (372.244)


Gentian Violet is only found in individuals that have used or taken this drug. It is a dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties. [PubChem]In aqueous solutions Gentian violet (GV) dissociates into positive (GV+)and negative ions (Cl-) that penetrate through the wall and membrane of both gram-positive and gram-negative bacterial cells. The GV+ interacts with negatively charged components of bacterial cells including the lipopolysaccharide (on the cell wall), the peptidoglycan and DNA. A similar cell penetration and DNA binding process is thought to take place for fungal cells as well. Because Gentian violet is a mutagen and mitotic poison, cell growth is consequently inhibited. A photodynamic action of gentian violet, apparently mediated by a free-radical mechanism, has recently been described in bacteria and in the protozoan T. cruzi. Evidence also suggests that gentian violet dissipates the bacterial (and mitochondrial) membrane potential by inducing permeability. This is followed by respiratory inhibition. This anti-mitochondrial activity might explain gentian violets efficacy towards both bacteria and yeast with relatively mild effects on mammalian cells.

   

Polyrhacitide B

Polyrhacitide B

C20H36O6 (372.2512)


   

14-Hydroxy-12,13-dihydrosesquiterpineol-14-O-xylopyranoside

14-Hydroxy-12,13-dihydrosesquiterpineol-14-O-xylopyranoside

C20H36O6 (372.2512)


   

Thromboxane B1

9S,11,15S-trihydroxy-thrombox-13E-enoic acid

C20H36O6 (372.2512)


   
   

Norvangiformsaeure

Norvangiformsaeure

C20H36O6 (372.2512)


   

(4R,6R,10R,12R)-4,10-dihydroxy-2,8-dioxo-6,12-dipentyl-1,7-dioxacyclododecane|4R,6R,10R,12R,4,10-Dihydroxy-2,8-dioxo-6,12-dipentyl-1,7-dioxacyclododecane|Verbalactone

(4R,6R,10R,12R)-4,10-dihydroxy-2,8-dioxo-6,12-dipentyl-1,7-dioxacyclododecane|4R,6R,10R,12R,4,10-Dihydroxy-2,8-dioxo-6,12-dipentyl-1,7-dioxacyclododecane|Verbalactone

C20H36O6 (372.2512)


   

dolabriferol B

dolabriferol B

C20H36O6 (372.2512)


   

heptadecane-1,2,3-tricarboxylic acid

heptadecane-1,2,3-tricarboxylic acid

C20H36O6 (372.2512)


   
   
   
   
   

valylvalylarginine

valylvalylarginine

C16H32N6O4 (372.2485)


   
   
   
   

Crystal Violet

Crystal Violet

[C25H30N3]+ (372.244)


[Raw Data] CB146_Crystal-violet_pos_50eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_40eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_30eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_20eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_10eV_CB000055.txt

   

Norrangiformic acid

Norrangiformic acid

C20H36O6 (372.2512)


   

TXB1

TXB1

C20H36O6 (372.2512)


CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0155.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0155.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0155.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]

   
   
   

19(R)-hydroxy-PGF1&alpha

9S,11R,15S-19R-tetrahydroxy-13E-prostaenoic acid

C20H36O6 (372.2512)


   

13,14-dihydro-19(R)-hydroxyPGE1

9-oxo-11R,15S,19R-trihydroxy-prostanoic acid

C20H36O6 (372.2512)


   

15(R),19(R)-hydroxy Prostaglandin F1&alpha

9α,11α,15R,19R-tetrahydroxy-prost-13E-en-1-oic acid

C20H36O6 (372.2512)


   

11-dehydro Thromboxane B2-d4

11-dehydro Thromboxane B2-d4

C20H28D4O6 (372.245)


   

FA 20:2;O4

9S,11R,15S,19R-tetrahydroxy-13E-prostaenoic acid

C20H36O6 (372.2512)


   

11-dehydro-TXB2-d4

9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid-d4

C20H28D4O6 (372.245)


   

ascr#23

13R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-tetradecenoic acid

C20H36O6 (372.2512)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,13R)-13-hydroxytetradec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

oscr#23

14-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-tetradecenoic acid

C20H36O6 (372.2512)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-14-hydroxytetradec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

Dicyclohexyl 18-crown-6

Dicyclohexyl 18-crown-6

C20H36O6 (372.2512)


   

2(3)-(tetrahydrofurfuryloxy)tetrahydropyran

2(3)-(tetrahydrofurfuryloxy)tetrahydropyran

C20H36O6 (372.2512)


   

(S)-α-Azidobenzenepropanoic acid (dicyclohexylammonium) salt

(S)-α-Azidobenzenepropanoic acid (dicyclohexylammonium) salt

C21H32N4O2 (372.2525)


   

(1R,3R,4S)-4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-2-METHYLENECYCLOPENTANOL

(1R,3R,4S)-4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-2-METHYLENECYCLOPENTANOL

C19H40O3Si2 (372.2516)


   

tert-butyl 4-(3,3-diethyl-2-oxoindol-1-yl)piperidine-1-carboxylate

tert-butyl 4-(3,3-diethyl-2-oxoindol-1-yl)piperidine-1-carboxylate

C22H32N2O3 (372.2413)


   

1-(1-ethynylcyclohexyl)oxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-ol

1-(1-ethynylcyclohexyl)oxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-ol

C22H32N2O3 (372.2413)


   

rac-1-Linoleoyl-3-chloropropanediol

rac-1-Linoleoyl-3-chloropropanediol

C21H37ClO3 (372.2431)


   

N,Nμ-Bis(4-butylphenyl)benzene-1,4-diamine

N,Nμ-Bis(4-butylphenyl)benzene-1,4-diamine

C26H32N2 (372.2565)


   

5-HYDROXYINDOLE-3-ACETIC ACID DICYCLOHEXYLAMMONIUM SALT

5-HYDROXYINDOLE-3-ACETIC ACID DICYCLOHEXYLAMMONIUM SALT

C22H32N2O3 (372.2413)


   

(2E,13R)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tetradec-2-enoic acid

(2E,13R)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tetradec-2-enoic acid

C20H36O6 (372.2512)


   

(2E)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tetradec-2-enoic acid

(2E)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tetradec-2-enoic acid

C20H36O6 (372.2512)


   

(6aS,9R,10R,10aS)-9-ethenyl-10-isocyano-6,6,9-trimethyl-1-(2-methylbut-3-en-2-yl)-2,6,6a,7,8,9,10,10a-octahydronaphtho[1,2,3-cd]indole

(6aS,9R,10R,10aS)-9-ethenyl-10-isocyano-6,6,9-trimethyl-1-(2-methylbut-3-en-2-yl)-2,6,6a,7,8,9,10,10a-octahydronaphtho[1,2,3-cd]indole

C26H32N2 (372.2565)


   

[3-carboxy-2-[(E)-11-carboxyundec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-9-enoyl]oxypropyl]-trimethylazanium

C19H34NO6+ (372.2386)


   

[3-carboxy-2-[(E)-11-carboxyundec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-2-enoyl]oxypropyl]-trimethylazanium

C19H34NO6+ (372.2386)


   

[3-carboxy-2-[(E)-11-carboxyundec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-7-enoyl]oxypropyl]-trimethylazanium

C19H34NO6+ (372.2386)


   

[3-carboxy-2-[(E)-11-carboxyundec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-8-enoyl]oxypropyl]-trimethylazanium

C19H34NO6+ (372.2386)


   

[3-carboxy-2-[(E)-11-carboxyundec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-6-enoyl]oxypropyl]-trimethylazanium

C19H34NO6+ (372.2386)


   

1-[1-(1-Cyclopentyl-5-tetrazolyl)-2-methylpropyl]-4-(2-fluorophenyl)piperazine

1-[1-(1-Cyclopentyl-5-tetrazolyl)-2-methylpropyl]-4-(2-fluorophenyl)piperazine

C20H29FN6 (372.2438)


   

6-(Dimethylamino)-2-{4-[4-(dimethylamino)phenyl]buta-1,3-dien-1-yl}-1-ethylquinolinium

6-(Dimethylamino)-2-{4-[4-(dimethylamino)phenyl]buta-1,3-dien-1-yl}-1-ethylquinolinium

C25H30N3+ (372.244)


   
   
   
   

Gentian violet cation

Gentian violet cation

C25H30N3+ (372.244)


   

19R-hydroxy-PGF1alpha

19R-hydroxy-PGF1alpha

C20H36O6 (372.2512)


   

13,14-dihydro-19R-hydroxyPGE1

13,14-dihydro-19R-hydroxyPGE1

C20H36O6 (372.2512)


   

ambiguine H

ambiguine H

C26H32N2 (372.2565)


An ambiguine which is a (6aS,9R,10R,10aS)-9-ethenyl-10-isocyano-6,6,9-trimethyl-1-(2-methylbut-3-en-2-yl) substituted derivative of 2,6,6a,7,8,9,10,10a-octahydronaphtho[1,2,3-cd]indole. An antimicrobial agent isolated from the cyanobacterium strain, Fischerella.

   

13,14-Dihydro-19R-hydroxy-PGE1

13,14-Dihydro-19R-hydroxy-PGE1

C20H36O6 (372.2512)


   

Dihydro-19R-hydroxy-PGE1

Dihydro-19R-hydroxy-PGE1

C20H36O6 (372.2512)


   

Hydroxy-PGF1alpha

Hydroxy-PGF1alpha

C20H36O6 (372.2512)


   
   

Deoxy-oleandolide

Deoxy-oleandolide

C20H36O6 (372.2512)


   

(2r,3s,4s,7r)-4-ethenyl-3-isocyano-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraene

(2r,3s,4s,7r)-4-ethenyl-3-isocyano-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraene

C26H32N2 (372.2565)


   

(2r,3r,4r,7s)-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraene-3-carbonitrile

(2r,3r,4r,7s)-4-ethenyl-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraene-3-carbonitrile

C26H32N2 (372.2565)


   

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3s,4s)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3s,4s)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

C20H36O6 (372.2512)


   

4-ethenyl-3-isocyano-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraene

4-ethenyl-3-isocyano-4,8,8-trimethyl-15-(2-methylbut-3-en-2-yl)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),9(16),10,12-tetraene

C26H32N2 (372.2565)


   

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3r,4s)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3r,4s)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

C20H36O6 (372.2512)


   

ambiguine h isonitrile

ambiguine h isonitrile

C26H32N2 (372.2565)


   

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3s,4r)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3s,4r)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

C20H36O6 (372.2512)


   

(4r,6r,10r,12r)-4,10-dihydroxy-6,12-dipentyl-1,7-dioxacyclododecane-2,8-dione

(4r,6r,10r,12r)-4,10-dihydroxy-6,12-dipentyl-1,7-dioxacyclododecane-2,8-dione

C20H36O6 (372.2512)


   

(1s,2s,4ar,4bs,7r,10as)-7-(1,2-dihydroxyethyl)-1-(hydroxymethyl)-1,4a,7-trimethyl-decahydrophenanthrene-2,8a,9-triol

(1s,2s,4ar,4bs,7r,10as)-7-(1,2-dihydroxyethyl)-1-(hydroxymethyl)-1,4a,7-trimethyl-decahydrophenanthrene-2,8a,9-triol

C20H36O6 (372.2512)


   

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3r,4r)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

(1r,2s,3s,4r,4as,8as)-3,4a,8,8-tetramethyl-4-[(1e,3r,4r)-3,4,5-trihydroxy-3-methylpent-1-en-1-yl]-hexahydro-1h-naphthalene-1,2,3-triol

C20H36O6 (372.2512)


   

(2r,3r,4r,5s)-2-{[(2s)-5-[(4s)-4-(2-hydroxypropan-2-yl)cyclohex-1-en-1-yl]-2-methylpentyl]oxy}oxane-3,4,5-triol

(2r,3r,4r,5s)-2-{[(2s)-5-[(4s)-4-(2-hydroxypropan-2-yl)cyclohex-1-en-1-yl]-2-methylpentyl]oxy}oxane-3,4,5-triol

C20H36O6 (372.2512)


   

3,4a,8,8-tetramethyl-4-(3,4,5-trihydroxy-3-methylpent-1-en-1-yl)-hexahydro-1h-naphthalene-1,2,3-triol

3,4a,8,8-tetramethyl-4-(3,4,5-trihydroxy-3-methylpent-1-en-1-yl)-hexahydro-1h-naphthalene-1,2,3-triol

C20H36O6 (372.2512)


   

(4s,6r,10s,12r)-4,10-dihydroxy-6,12-dipentyl-1,7-dioxacyclododecane-2,8-dione

(4s,6r,10s,12r)-4,10-dihydroxy-6,12-dipentyl-1,7-dioxacyclododecane-2,8-dione

C20H36O6 (372.2512)


   

7-(1,2-dihydroxyethyl)-1-(hydroxymethyl)-1,4a,7-trimethyl-decahydrophenanthrene-2,8a,9-triol

7-(1,2-dihydroxyethyl)-1-(hydroxymethyl)-1,4a,7-trimethyl-decahydrophenanthrene-2,8a,9-triol

C20H36O6 (372.2512)


   

4,10-dihydroxy-6,12-dipentyl-1,7-dioxacyclododecane-2,8-dione

4,10-dihydroxy-6,12-dipentyl-1,7-dioxacyclododecane-2,8-dione

C20H36O6 (372.2512)


   

(1s,2s,4ar,4bs,7r,8as,9s,10as)-7-[(1s)-1,2-dihydroxyethyl]-1-(hydroxymethyl)-1,4a,7-trimethyl-decahydrophenanthrene-2,8a,9-triol

(1s,2s,4ar,4bs,7r,8as,9s,10as)-7-[(1s)-1,2-dihydroxyethyl]-1-(hydroxymethyl)-1,4a,7-trimethyl-decahydrophenanthrene-2,8a,9-triol

C20H36O6 (372.2512)